Press Release
Biovaxys And Procare Health Announce Joint Commercialization And Marketing Collaboration For Cancer And Viral Vaccines
USD$900,000 In-Kind Investment by Procare Health into Phase I Clinical Study for BVX-0918A in the EU Co-Development of Vaccines for Cervical Cancer...